JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257177

Human DDB2 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

DDB2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1 and 29 bp deletion in exon1 and 2 bp insertion in exon1.

View Alternative Names

DDB p48 subunit, DDB2_HUMAN, DDBb, DNA damage-binding protein 2, Damage-specific DNA-binding protein 2, UV-DDB 2, UV-damaged DNA-binding protein 2, Xeroderma pigmentosum group E protei

4 Images
Western blot - Human DDB2 knockout HeLa cell lysate (AB257177)
  • WB

Unknown

Western blot - Human DDB2 knockout HeLa cell lysate (AB257177)

Lane 1 : Wild-type HeLa cell lysate (20 μg)

Lane 2 : DDB2 knockout HeLa cell lysate (20 μg)

Lane 3 : Raji cell lysate (20 μg)

Lanes 1-3 : Merged signal (red and green). Green - ab181136 observed at 48 kDa. Red - loading control, ab8245 observed at 37 kDa.

ab181136 Anti-DDB2 antibody [EPR9811] was shown to specifically react with DDB2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265115 (knockout cell lysate ab257177) was used. Wild-type and DDB2 knockout samples were subjected to SDS-PAGE. ab181136 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-DDB2 antibody [EPR9811] (<a href='/en-us/products/primary-antibodies/ddb2-antibody-epr9811-ab181136'>ab181136</a>) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

DDB2 knockout HeLa cell lysate at 20 µg

Lane 3:

Raji cell lysate at 20 µg

Predicted band size: 48 kDa

Observed band size: 48 kDa

false

Sanger Sequencing - Human DDB2 knockout HeLa cell lysate (AB257177)
  • Sanger seq

Unknown

Sanger Sequencing - Human DDB2 knockout HeLa cell lysate (AB257177)

Allele-1 : 29 bp deletion in exon1

Sanger Sequencing - Human DDB2 knockout HeLa cell lysate (AB257177)
  • Sanger seq

Unknown

Sanger Sequencing - Human DDB2 knockout HeLa cell lysate (AB257177)

Allele-2 : 1 bp insertion in exon1

Sanger Sequencing - Human DDB2 knockout HeLa cell lysate (AB257177)
  • Sanger seq

Unknown

Sanger Sequencing - Human DDB2 knockout HeLa cell lysate (AB257177)

Allele-3 : 2 bp insertion in exon1

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1 and 29 bp deletion in exon1 and 2 bp insertion in exon1.

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257177-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human DDB2 knockout HeLa cell lysate", "number":"AB257177-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB257177-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
DDB2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

DDB2 also known as DNA damage-binding protein 2 plays a mechanical role in the nucleotide excision repair (NER) pathway. It is a part of the UV-damaged DNA-binding protein complex and assists in recognizing and cutting damaged DNA. The mass of DDB2 is approximately 48 kDa. The expression of DDB2 occurs broadly but it shows enhanced expression in tissues exposed to UV light like skin.
Biological function summary

Engagement in DNA repair mechanisms allows DDB2 to help maintain genomic stability. It forms a critical part of the DDB1-DDB2 complex which collaborates with other proteins in the initial damage recognition step of NER. This involvement ensures the repair of UV-induced damage and bulky DNA adducts preventing mutations that can cause harmful genetic alterations.

Pathways

The involvement of DDB2 is important within the nucleotide excision repair and transcription-coupled repair pathways. In these pathways DDB2 partners with proteins such as XPC and XPA facilitating the recognition and verification of DNA damage. These interactions ensure an accurate and efficient repair process protecting cells from potential genotoxic stress.

DDB2 has relevance to skin cancer and xeroderma pigmentosum. Among these mutations or dysregulation involving DDB2 can lead to skin cancer due to impaired DNA repair response to UV damage. It connects to p53 a protein that regulates the cell cycle and likewise contributes to cellular responses against DNA damage. In xeroderma pigmentosum defects in components of the NER pathway including DDB2 lead to extreme sensitivity to sunlight and subsequent skin abnormalities.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com